Congressman Stephen F. Lynch (D-Boston) released the following statement regarding his endorsement of Congressman Tim Ryan of Ohio for Democratic Leader.
Lynch Again Calls on FERC to Halt Pipeline Projects in West Roxbury and Weymouth Following Pipeline Explosions
In the wake of the recent fatal natural gas pipeline explosion in Canton, Illinois, Congressman Lynch called on FERC to halt the permitting process and construction for the proposed Spectra pipelines in West Roxbury and Weymouth, Massachusetts.
Lynch Calls on FERC to Halt Pipeline Projects in West Roxbury and Weymouth Following Pipeline Explosions
In the wake of the recent fatal pipeline explosion in Alabama, Congressman Stephen F. Lynch called on the Federal Energy Regulatory Commission to halt the permitting process and construction for the proposed Spectra pipelines in West Roxbury and Weymouth, Massachusetts.
Congressman Stephen F. Lynch (D-Boston) announced nearly $1.7 million in federal funding for the Town of Scituate to fortify the Third Cliff seawall.
Congressman Lynch and members of the Massachusetts Congressional delegation sent a letter to Massachusetts Treasurer Deborah Goldberg calling for the Commonwealth of Massachusetts to end any business arrangements with Wells Fargo.
Congressman Lynch wrote an op-ed for The Hill highlighting the need for greater pricing transparency and other reforms in the wake of Mylan's EpiPen price hikes.
The United States House of Representatives unanimously passed the bipartisan Veterans Day Moment of Silence Act under unanimous consent.
On Sunday, October 2, Congressman Lynch will host an information session for all high school students in the Eighth Congressional District interested in applying to one of the United States Service Academies.
Congressman Lynch and U.S. Senators Warren and Markey announced that the Massachusetts Bay Transportation Authority will receive $4.2M in grant funding through the U.S. Department of Transportation’s Buses and Bus Facilities Competitive Grant Program.
Congressman Lynch called on the House Oversight and Government Reform Committee to hold a hearing to examine Mylan’s pricing practices after the dramatic cost increase for the EpiPen.